These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9785450)

  • 1. Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine.
    Tiraby M; Cazaux C; Baron M; Drocourt D; Reynes JP; Tiraby G
    FEMS Microbiol Lett; 1998 Oct; 167(1):41-9. PubMed ID: 9785450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
    Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
    Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
    Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system.
    Miyagi T; Koshida K; Hori O; Konaka H; Katoh H; Kitagawa Y; Mizokami A; Egawa M; Ogawa S; Hamada H; Namiki M
    J Gene Med; 2003 Jan; 5(1):30-7. PubMed ID: 12516049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Adachi Y; Tamiya T; Ichikawa T; Terada K; Ono Y; Matsumoto K; Furuta T; Hamada H; Ohmoto T
    Hum Gene Ther; 2000 Jan; 11(1):77-89. PubMed ID: 10646641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
    Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
    Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.
    Kuriyama S; Masui K; Sakamoto T; Nakatani T; Kikukawa M; Tsujinoue H; Mitoro A; Yamazaki M; Yoshiji H; Fukui H; Ikenaka K; Mullen CA; Tsujii T
    Anticancer Res; 1998; 18(5A):3399-406. PubMed ID: 9858915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
    Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
    Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.
    Erbs P; Regulier E; Kintz J; Leroy P; Poitevin Y; Exinger F; Jund R; Mehtali M
    Cancer Res; 2000 Jul; 60(14):3813-22. PubMed ID: 10919655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
    Porosnicu M; Mian A; Barber GN
    Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells.
    Matuskova M; Baranovicova L; Kozovska Z; Durinikova E; Pastorakova A; Hunakova L; Waczulikova I; Nencka R; Kucerova L
    J Gene Med; 2012 Dec; 14(12):776-87. PubMed ID: 23150190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective in vivo radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells transduced with the E. coli cytosine deaminase (CD) gene.
    Gabel M; Kim JH; Kolozsvary A; Khil M; Freytag S
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):883-7. PubMed ID: 9652853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
    Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
    BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
    Garcia-Sanchez F; Pizzorno G; Fu SQ; Nanakorn T; Krause DS; Liang J; Adams E; Leffert JJ; Yin LH; Cooperberg MR; Hanania E; Wang WL; Won JH; Peng XY; Cote R; Brown R; Burtness B; Giles R; Crystal R; Deisseroth AB
    Blood; 1998 Jul; 92(2):672-82. PubMed ID: 9657770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of the uracil phosphoribosyltransferase gene with a chimeric human nerve growth factor receptor/cytosine deaminase fusion gene, using a single retroviral vector, augments cytotoxicity of transduced human T cells exposed to 5-fluorocytosine.
    O'Brien TA; Tuong DT; Basso LM; McIvor RS; Orchard PJ
    Hum Gene Ther; 2006 May; 17(5):518-30. PubMed ID: 16716109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.
    Hamstra DA; Lee KC; Tychewicz JM; Schepkin VD; Moffat BA; Chen M; Dornfeld KJ; Lawrence TS; Chenevert TL; Ross BD; Gelovani JT; Rehemtulla A
    Mol Ther; 2004 Nov; 10(5):916-28. PubMed ID: 15509509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
    Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
    Kievit E; Nyati MK; Ng E; Stegman LD; Parsels J; Ross BD; Rehemtulla A; Lawrence TS
    Cancer Res; 2000 Dec; 60(23):6649-55. PubMed ID: 11118048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
    Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
    Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conditional negative selection for Arabidopsis expressing a bacterial cytosine deaminase gene.
    Kobayashi T; Hisajima S; Stougaard J; Ichikawa H
    Jpn J Genet; 1995 Jun; 70(3):409-22. PubMed ID: 7632443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.